| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2009 | CN101412758A Anti-ErbB2 antibodies |
| 04/22/2009 | CN101412754A Gastrin compositions and formulations, and methods of use and preparation |
| 04/22/2009 | CN101412749A MUC1 tandem repeat sequences polypeptide, preparation technique thereof and use as anti-tumor medicament |
| 04/22/2009 | CN101412747A Novel cell-penetrating peptide and uses thereof |
| 04/22/2009 | CN101411878A Method for anchoring growth factor on material with biodegradability |
| 04/22/2009 | CN101411876A Neurotoxic oligomers |
| 04/22/2009 | CN101411871A Method for preparing chicken thymosin long-acting dosage form |
| 04/22/2009 | CN101411870A Method for preparing chicken interferon long-acting sustained-release dosage form |
| 04/22/2009 | CN101411869A Method for preparing pig interferon long-acting injection dosage form |
| 04/22/2009 | CN101411868A Method for preparing dog interferon long-acting injection dosage form |
| 04/22/2009 | CN101411867A Method for preparing chicken interleukin-2 long-acting dosage form |
| 04/22/2009 | CN101411866A Polypeptide medicament for treating highly pathogenic bird flu virus H5N1induced disease |
| 04/22/2009 | CN101411865A Use of compound acimetion enkephalins in preparing medicament for treating intestinal cancer and pancreatic cancer |
| 04/22/2009 | CN101411864A Thymopentin dry powder formulation and preparation method thereof |
| 04/22/2009 | CN101411494A Corn peptide beverage for sobering-up and preparation method thereof |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480374C Process for preparing recombination human glicentin-1(7-37) |
| 04/22/2009 | CN100480274C Hydroxyalkyl starch derivatives |
| 04/22/2009 | CN100480269C Anti-vegf antibodies |
| 04/22/2009 | CN100480267C Corticotropin releasing factor 2 receptor agonists |
| 04/22/2009 | CN100480266C Interferon-beta fusion proteins and uses |
| 04/22/2009 | CN100480264C Earthworm protein suppressing cancer cell accretion by road spectrum and coding sequence thereof |
| 04/22/2009 | CN100480263C Immunosuppressive receptor derived from dendritic cell, coding sequence and uses thereof |
| 04/22/2009 | CN100480259C Telomerase inhibitory peptides and uses thereof |
| 04/22/2009 | CN100480258C Purified LH (Luteinizing hormone) |
| 04/22/2009 | CN100479857C Anti-HIV medicine |
| 04/22/2009 | CN100479856C Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 04/22/2009 | CN100479855C Active bone peptide for treating and preventing osteoporosis and preparing method thereof |
| 04/21/2009 | US7521539 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 04/21/2009 | US7521536 Expression vector comprising nucleotide sequences coding membrane transport protein for use in prevention and treatment of neurodegenerative disease |
| 04/21/2009 | US7521535 Anti-microbial defensin-related peptides and methods of use |
| 04/21/2009 | US7521532 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment immunological and autoimmune diseases |
| 04/21/2009 | US7521531 Methods for the purification of stable radioiodine conjugates |
| 04/21/2009 | US7521530 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
| 04/21/2009 | US7521529 Lantibiotics; biosynthesis; solid phase synthesis; deblocking, deprotecting |
| 04/21/2009 | US7521528 Point mutations; for treating conditions characterized by decreases in bone mass such as osteoporosis |
| 04/21/2009 | US7521527 Glucagon-like peptide-1 (GLP-1); for treatment of diabetes, obesity, excessive appetite, insufficient satiety, and metabolic disorders; for converting liver stem/progenitor cells into functional pancreatic cells |
| 04/21/2009 | US7521477 Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same |
| 04/21/2009 | US7521466 Dipeptide phenyl ethers |
| 04/21/2009 | US7521431 Compositions and methods for siRNA inhibition of HIF-1 alpha |
| 04/21/2009 | US7521426 Peptides and DNA encoding peptides that carry novel cytotoxic T lymphocyte epitopes derived from fragments of human immunodeficiency virus-1 Pol or envelope proteins and carry HLA-A*1101 binding motif; vaccines |
| 04/21/2009 | US7521425 Conjugated to antibody; thrombospondin receptor targeting |
| 04/21/2009 | US7521424 Albumin fusion proteins |
| 04/21/2009 | US7521423 Exendin pharmaceutical compositions |
| 04/21/2009 | US7521422 Use of aspartic proteases in cosmetics and therapeutics |
| 04/21/2009 | US7521421 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 04/21/2009 | US7521420 Macrocyclic antagonists of the motilin receptor |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521418 When used in combination with glycopeptide antibacterial agent, the amount of polyene macrolide antifungal agent needed to treat a fungal infection is reduced thereby resulting in fewer side effects |
| 04/21/2009 | US7521417 Method and apparatus for preparing an acellular red blood cell substitute |
| 04/21/2009 | US7521416 D-amino acid peptides |
| 04/21/2009 | US7521415 Methods of intracellular peptide delivery |
| 04/21/2009 | US7521258 Methods of detecting, measuring, and evaluating modulators of body weight in biological samples, and diagnostic, monitoring, and therapeutic uses thereof |
| 04/21/2009 | US7521239 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 04/21/2009 | US7521233 Providing to endothelial cells cultured on a porous matrix or scaffold that supports tissue growth in vitro an amount of an osteoprotegerin |
| 04/21/2009 | US7521222 Farnesyl dibenzodiazepinone and processes for its production |
| 04/21/2009 | US7521216 Nitrilases and methods for making and using them |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521210 Method for large-scale production of polypeptide in eukaryote cells and a culture vessel suitable therefor |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521197 Method for producing cytotoxic T-cells |
| 04/21/2009 | US7521193 Human diabetes-mediating proteins |
| 04/21/2009 | US7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/21/2009 | US7521070 Powder of ossified horns of reindeer and containing endorphins in the form of agent for preventing and treating pathological states associated with endorphin deficiency; drug abuse, drug dependence |
| 04/21/2009 | US7521069 Methods and compositions for pulmonary delivery of insulin |
| 04/21/2009 | US7521068 For pulmonary and nasal drug administration |
| 04/21/2009 | US7521061 Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
| 04/21/2009 | US7521057 Lamprey GnRH-III polypeptides and methods of making thereof |
| 04/21/2009 | US7521056 Fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 04/21/2009 | US7521049 Administering fusion proteins, immunoglobulins, and multimeric proteins; pharmacokinetics; age-related macular degeneration and diabetic retinopathy |
| 04/21/2009 | US7521044 Human histone deacetylase, HDAC9c |
| 04/21/2009 | US7521043 Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
| 04/21/2009 | CA2434964C Carrier with solid fibrinogen and solid thrombin |
| 04/21/2009 | CA2378537C Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 04/21/2009 | CA2338358C Compounds and compositions for delivering active agents |
| 04/21/2009 | CA2336902C Topical compositions comprising an opioid analgesic and an nmda antagonist |
| 04/21/2009 | CA2309038C Use of inhaled no as anti-inflammatory agent |
| 04/21/2009 | CA2289122C Bak promoter expression system |
| 04/21/2009 | CA2231603C Chicken interleukin-15 and uses thereof |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2182034C Treatment for juvenile diabetes |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/16/2009 | WO2009049234A2 Methods of treating coagulopathy |
| 04/16/2009 | WO2009049222A1 Compositions and methods of using the human proislet peptide receptor |
| 04/16/2009 | WO2009048980A2 Emp2 antibodies and their therapeutic uses |
| 04/16/2009 | WO2009048967A1 Combination therapy with antibody-drug conjugates |
| 04/16/2009 | WO2009048959A1 Rapid acting injectable insulin compositions |
| 04/16/2009 | WO2009048945A1 Rapid mucosal gel or film insulin compositions |
| 04/16/2009 | WO2009048929A1 Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| 04/16/2009 | WO2009048909A1 Compositions and methods for ribonuclease-based therapies |
| 04/16/2009 | WO2009048870A1 Peptide dendrimers: affinity reagents for binding noroviruses |
| 04/16/2009 | WO2009048658A2 Optimized dengue virus entry inhibitory peptide (dn81) |
| 04/16/2009 | WO2009048343A1 Functional lipid constructs |
| 04/16/2009 | WO2009048314A1 A scalable matrix for the in vivo cultivation of bone and cartilage |
| 04/16/2009 | WO2009048306A1 Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium |
| 04/16/2009 | WO2009048280A2 Long acting hyaluronic acid - peptide conjugate |
| 04/16/2009 | WO2009048166A1 Therapeutic agent for heart disease, which is intended to be used in cell transplantation therapy |
| 04/16/2009 | WO2009048119A1 Medicinal composition containing highly functionalized chimeric protein |
| 04/16/2009 | WO2009048072A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 04/16/2009 | WO2009048067A1 Genetically engineered blood coagulation factor x having no sugar chain, and method for production thereof |